(Q73225545)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Changes in plasma cytokines induced by interferon-beta1a treatment in patients with multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

M E Duddy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M A Armstrong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A D Crockard

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S A Hawkins

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

98-109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1 a) products administered intramuscularly in healthy male and female volunteers

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Interleukin-6 is elevated in plasma in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-γ in multiple sclerosis CSF and serum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

The cytokine storm in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Influence of IFN-beta1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900103-4

7 January 2021

10.1016/S0165-5728(99)00103-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10580818%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference